• Vinay Guduguntla and Rita F Redberg.
• Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94131, United States. Electronic address: vinay.guduguntla@ucsf.edu.
• Eur. J. Intern. Med. 2021 Dec 1; 94: 15-21.

AbstractDespite limited benefit, percutaneous coronary intervention (PCI) remains a common procedure that is often performed for uncertain or inappropriate indications in patients with stable coronary artery disease (CAD). PCI cases per capita have increased year-over-year in most European countries, and many have higher rates than the U.S. Meanwhile, first-line therapy such as optimal medical therapy (OMT) and lifestyle changes, continue to be under-utilized. This article reviews the evidence on use of PCI in stable CAD. Specifically, we analyzed randomized control trials, systematic reviews, appropriate use criteria, and professional society guidelines that examine the risks and benefits of PCI compared to OMT. We then highlight utilization patterns as well as interventions that better align current practice with evidence-based care.Copyright © 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

8 keywords...

hide…